Status:

WITHDRAWN

Investigating the Novel Observation of Right-left Difference in Uterine Artery Vascular Resistance in Pre-eclampsia

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Pre-eclampsia

Eligibility:

FEMALE

18-40 years

Phase:

PHASE3

Brief Summary

The investigators previously demonstrated that epidural ropivacaine reduces uterine artery vascular resistance in a dose dependent manner in pre-eclampsia. The investigators also noted a marked right-...

Eligibility Criteria

Inclusion

  • Pre-eclampsia patients and normal pregnancy controls scheduled to receive epidural catheterization for induction of labor or Cesarean delivery. Non-pregnant controls receiving epidural catheterization for elective surgery. Pre-eclampsia group:
  • gestational age between 35 to 40 completed weeks
  • uterine artery notching OR evidence of reduced uterine artery blood flow
  • resting systolic pressure \> 140mmHg or diastolic pressure \> 90mmHg measured twice at least 6 hours apart
  • proteinuria (at least 0•1 g/l in two random samples at least 6 hours apart or at least 0•3g in a 24 hour collection).
  • Normal pregnancy control group:
  • gestational age between 35 to 40 completed weeks
  • absence of other inclusion factors for the pre-eclampsia group. Non-pregnant control group: Non-pregnant women of reproductive age.

Exclusion

  • Active labor, resting blood pressure ≥ 160/110 (recorded on at least two occasions 6 hours apart), coagulopathy or other contraindications for epidural catheterization, abnormal fetal heart tracing, known fetal anomaly, intrauterine infection, placental anomalies, twins, and refusal of consent.

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00848679

Start Date

March 1 2009

End Date

October 1 2009

Last Update

September 12 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hadassah Hebrew University Medical Center

Jerusalem, Israel, 91120